Medical Research Continues to Lose Integrity

Senator Charles E. Grassley has raised some serious concern over a recent article published in the Elsevier Medical Journal. The Senator has asked the publisher to investigate an article written on hormone replacement therapy, believing that it was improperly “ghostwritten” by a drug company promoting their products. The article was part of an editor’s choice section in Elsevier’s Journal of Obstetrics and Gynecology. In an article signed by Dr. John Eden of Australia, Senator Grassley has found unethical promotions lacking scientific evidence. At the heart of the controversy is the drug company Wyeth. Mr. Grassley, a member of the Senate … [Read more...]

Morphine, Dextroamphetamine, and Isosorbide added to the Ethex Recall

The Ethex Corporation has added three new drugs to its list of recently recalled products.  After Ethex discovered that their propafenone tablets were over-sized, it became evident that many other drugs being manufactured by the company were also over-sized.  Isosorbide Isosorbide is a drug used principally in the treatment of angina. It works by dilating the blood vessels in order to reduce blood pressure. All of the recalled Isosorbide Mononitrate tablets said they were 60mg on the bottle and were made by the ETHEX Corporation with expiration dates ranging from 12/2008 and 11/2009. Recalled lot numbers: 63466, 66034, 67351, and … [Read more...]